keyword
https://read.qxmd.com/read/38201918/subclinical-hypothyroidism-in-patients-with-obesity-and-metabolic-syndrome-a-narrative-review
#21
REVIEW
Bernadette Biondi
The literature on the connection between obesity, metabolic syndrome, and subclinical hypothyroidism is critically analyzed in this narrative review. These conditions are frequently observed among adult populations and various studies and meta-analyses have assessed their association. The prevalence of subclinical hypothyroidism in obese individuals is higher than in non-obese subjects and this trend is more pronounced in unhealthy obesity phenotypes. However, the diagnosis and treatment of subclinical hypothyroidism can be difficult in obese patients...
December 27, 2023: Nutrients
https://read.qxmd.com/read/38165911/subclinical-thyroid-dysfunction-and-the-risk-of-incident-atrial-fibrillation-a-systematic-review-and-meta-analysis
#22
JOURNAL ARTICLE
Hasveer Singh, Mariam Z Shahid, Stephanie L Harrison, Deirdre A Lane, Gregory Y H Lip, Sunil Jit R J Logantha
BACKGROUND: Thyroid hormones act on the cardiovascular system directly by modulating its function and indirectly by transcriptional regulation of gene expression in the heart and the vasculature. Studies have shown associations between overt and subclinical thyroid disorders and cardiovascular outcomes. The aim of this study was to perform a systematic review and meta-analysis to assess the potential relationships between subclinical hyper- and hypothyroidism and risk of atrial fibrillation (AF), and post-operative AF...
2024: PloS One
https://read.qxmd.com/read/38154030/effect-of-daily-zinc-supplementation-for-12%C3%A2-weeks-on-serum-thyroid-auto-antibody-levels-in-children-and-adolescents-with-autoimmune-thyroiditis%C3%A2-a-randomized-controlled-trial
#23
RANDOMIZED CONTROLLED TRIAL
Ramachandran Ramge Sivakumar, Delhikumar Chinnaiah Govindareddy, Jayaprakash Sahoo, Zachariah Bobby, Palanivel Chinnakali
OBJECTIVES: To assess the effect of daily zinc supplementation for 12 weeks on thyroid auto-antibodies - thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb), and oxidative stress in children with autoimmune thyroid disease (AITD) compared to standard therapy. METHODS: This open-labeled, parallel, randomized controlled trial was done in a tertiary care teaching institute in south India. Children aged 3-18 years with AITD were randomized to receive 25 mg elemental zinc daily for 12 weeks or standard therapy alone...
February 26, 2024: Journal of Pediatric Endocrinology & Metabolism: JPEM
https://read.qxmd.com/read/38124252/randomized-double-blind-placebo-controlled-trial-on-levothyroxine-and-liothyronine-combination-therapy-in-totally-thyroidectomized-subjects-the-levolio-study
#24
RANDOMIZED CONTROLLED TRIAL
Giulia Brigante, Daniele Santi, Gisella Boselli, Gianluca Margiotta, Rossella Corleto, Maria Laura Monzani, Andrea Craparo, Michela Locaso, Samantha Sperduti, Neena Roy, Livio Casarini, Tommaso Trenti, Simonetta Tagliavini, Maria Cristina De Santis, Laura Roli, Vincenzo Rochira, Manuela Simoni
OBJECTIVE: Despite having normal thyroid-stimulating hormone levels, many hypothyroid patients are dissatisfied with the treatment. The primary aim of this study was to evaluate the effect of twice-daily, combination therapy with levothyroxine (LT4) and liothyronine (LT3), at doses adapted according to TSH-level, on peripheral tissues as reflected by sex hormone binding globulin (SHBG) levels in totally thyroidectomized patients. Changes in other tissue markers and quality of life considering DIO2-rs225014 and MCT10-rs17606253 genetic variants were also assessed...
January 3, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38111709/effects-of-sars-cov-2-infection-on-hypothyroidism-and-subclinical-hypothyroidism-a-meta-analysis
#25
Jiaqi Wei, Fenghua Zhang
BACKGROUND: In recent years, the outbreak of COVID-19 caused by SARS-CoV-2 has been witnessed globally. However, the impact of SARS-CoV-2 infection on thyroid dysfunction and subclinical thyroid dysfunction remains unclear. Therefore, this meta-analysis aimed to assess the effects of SARS-CoV-2 infection on thyroid dysfunction and its relationship with the severity of COVID-19. METHODS: We systematically searched databases including PubMed, Willey Library, Embase, Web of Science, CNKI, Wanfang, and VIP...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/38106561/efficacy-and-safety-of-sintilimab-plus-albumin-bound-paclitaxel-in-recurrent-or-metastatic-cervical-cancer-a-multicenter-open-label-single-arm-phase-ii-trial
#26
JOURNAL ARTICLE
Yin Wang, Jing Zhao, Haixi Liang, Junxiu Liu, Shenjiao Huang, Guorong Zou, Xin Huang, Chunyan Lan
BACKGROUND: Sintilimab is an antibody against programmed cell death protein 1. We assessed the efficacy and safety of sintilimab plus albumin-bound (nab)-paclitaxel for the treatment of recurrent or metastatic cervical cancer. METHODS: This multicenter, open-label, single-arm, phase II study (ClinicalTrials.gov identifier NCT04341883) enrolled patients with recurrent or metastatic cervical cancer who progressed after at least one line of systemic therapy. The patients received sintilimab 200 mg and nab-paclitaxel 260 mg/m2 body surface area every 3 weeks...
November 2023: EClinicalMedicine
https://read.qxmd.com/read/38066549/the-safety-and-efficacy-of-tislelizumab-alone-or-in-combination-with-chemotherapy-for-the-treatment-of-non-small-cell-lung-cancer-a-systematic-review-of-clinical-trials
#27
JOURNAL ARTICLE
Amin Daei Sorkhabi, Mahta ZareDini, Asra Fazlollahi, Aila Sarkesh, Amirreza Naseri, Seyed Ehsan Mousavi, Seyed Aria Nejadghaderi, Mark J M Sullman, Ali-Asghar Kolahi, Saeid Safiri
BACKGROUND: Tislelizumab is an anti-programmed death-1 (PD-1) monoclonal antibody with a construction that enables it to have a higher affinity to its target. We aimed to evaluate tislelizumab's safety and efficacy for treating non-small cell lung cancer (NSCLC). METHODS: Embase, Scopus, PubMed, Web of Science, and Google Scholar were searched up to December 20, 2022. The review only included randomized controlled trials (RCTs) that evaluated the safety or efficacy of tislelizumab for treating patients with lung cancer...
December 8, 2023: BMC Pulmonary Medicine
https://read.qxmd.com/read/38048390/comparison-of-the-therapeutic-effects-of-15%C3%A2-mg-and-30%C3%A2-mg-initial-daily-prednisolone-doses-in-patients-with-subacute-thyroiditis-a-multicenter-randomized-open-label-parallel-controlled-trial
#28
RANDOMIZED CONTROLLED TRIAL
Jingjing Zeng, Aihua Jia, Juan Zhang, Bin Gao, Jing Xu, Ying Xing, Xiaorui Jing, Yang Jiao, Jie Wang, Wenlei Xu, Ling Gao, Lei Shang, Shaoyong Xu
INTRODUCTION: Current guidelines recommendations for the initial dose of prednisolone (PSL) in the treatment of subacute thyroiditis (SAT) are based on low-quality studies. We designed a randomized controlled trial (RCT) to compare the efficacy and safety of using a low initial dose of PSL with a standard initial dose of PSL in SAT patients. PATIENTS AND METHODS: This open-label RCT was conducted at five hospitals in China from June 2019 to January 2022. SAT patients with moderate-to-severe pain or a poor response to non-steroidal anti-inflammatory drugs (NSAIDs) were randomly assigned in a 1:1 ratio to the experimental and control groups...
2023: Annals of Medicine
https://read.qxmd.com/read/38034018/designing-a-combined-liothyronine-lt3-l-thyroxine-lt4-trial-in-symptomatic-hypothyroid-subjects-on-lt4-the-importance-of-patient-selection-choice-of-lt3-and-trial-design
#29
REVIEW
Lakdasa D Premawardhana, Peter Nicholas Taylor, Onyebuchi E Okosieme, Mohamed A Adlan, Emmanuel K Obuobie, Colin Mark Dayan
Approximately 10%-15% of subjects with hypothyroidism on L-thyroxine (LT4) alone have persistent symptoms affecting their quality of life (QoL). Although the cause is unclear, there is evidence that "tissue T3 lack" may be responsible. If so, combining liothyronine (LT3) with LT4 would be helpful. However, randomized controlled trials (RCT), have not established greater efficacy for the LT3 + LT4 combination in these subjects than for LT4 alone. While the trial design may have been responsible, the use of unphysiological, short-acting LT3 preparations and non-thyroid-specific patient-reported outcome measures (PROMs) may have contributed...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/38023239/apatinib-plus-chemotherapy-for-non-metastatic-osteosarcoma-a-retrospective-cohort-study
#30
JOURNAL ARTICLE
Jiaqiang Wang, Fan Zhang, Shuping Dong, Yang Yang, Fangfang Gao, Guancong Liu, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian
BACKGROUND: Effective adjuvant therapy for osteosarcoma is necessary for improved outcomes. Previous studies demonstrated that apatinib plus doxorubicin-based chemotherapy may improve the efficacy of neoadjuvant therapy. This study aimed to clarify the effectiveness and safety of apatinib plus doxorubicin and cisplatin (AP) as neoadjuvant therapy for osteosarcoma. METHODS: The clinical data of osteosarcoma patients who underwent neoadjuvant therapy and surgery between August 2016 and April 2022 were retrospectively collected and analyzed...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38004062/epidemiological-pathophysiological-and-clinical-considerations-on-the-interplay-between-thyroid-disorders-and-type-2-diabetes-mellitus
#31
REVIEW
Gregory Grigoriadis, Theocharis Koufakis, Kalliopi Kotsa
Thyroid disorders (TD) and diabetes mellitus (DM) are the two endocrinopathies with the highest prevalence in the general population that frequently coexist. Thyroid dysfunction is more common in people with type 2 diabetes mellitus (T2DM) compared to normoglycemic individuals. Untreated TD can impair glycemic control, increasing the risk of diabetes complications. Hyperinsulinemia can affect the morphology of the thyroid gland by promoting the proliferation of thyroid tissue and increasing the size of thyroid nodules...
November 16, 2023: Medicina
https://read.qxmd.com/read/37999992/effect-of-physical-exercise-in-people-with-hypothyroidism-systematic-review-and-meta-analysis
#32
REVIEW
Iratxe Duñabeitia, Daniel González-Devesa, Silvia Varela-Martínez, Jose Carlos Diz-Gómez, Carlos Ayán-Pérez
This study aimed to systematically revise the available evidence on the effects of physical exercise training programmes on people with hypothyroidism. Comparative studies were searched in six electronic databases until April 2023. The Physiotherapy Evidence Database and the Methodological Index for Non-Randomized Studies were used to determine the methodological quality of the randomized controlled trials and comparative studies respectively. A total of 10 studies were found showing a low to moderate methodological quality...
November 24, 2023: Scandinavian Journal of Clinical and Laboratory Investigation
https://read.qxmd.com/read/37969187/therapeutic-effect-of-vitamin-d-in-hashimoto-s-thyroiditis-a-prospective-randomized-and-controlled-clinical-trial-in-china
#33
JOURNAL ARTICLE
Xue Jiang, Yin Huang, Yanan Li, Yuxiao Xia, Lina Liu, Feng Lin, Yuhong Shi
BACKGROUND: The study aims to explore the clinical effects of Vitamin D (VitD) supplements for Hashimoto's Thyroiditis (HT), which are unclear according to other studies. METHODS: Female patients with newly diagnosed HT from January to June in 2018 were included. This study is registered in the Chinese Clinical Trials Registry with registration number ChiCTR1800014619 (URL: https://www.chictr.org.cn/). Patients were randomly assigned to the treatment group and the control group...
2023: American Journal of Translational Research
https://read.qxmd.com/read/37967804/systematic-review-and-meta-analysis-of-levothyroxine-effect-on-blood-pressure-in-patients-with-subclinical-hypothyroidism
#34
REVIEW
Bahar Darouei, Reza Amani-Beni, Amir Parsa Abhari, Mohammad Fakhrolmobasheri, Davood Shafie, Maryam Heidarpour
This study aims to evaluate the effect of levothyroxine therapy on blood pressure (BP) in patients with subclinical hypothyroidism (SCH). Were searched Six databases, and randomized controlled trials (RCT) and prospective cohort studies evaluating the effect of levothyroxine therapy on BP in patients with SCH were included. 37 articles (9 RCTs and 28 prospective cohorts) were included in this meta-analysis. Pooled analysis of RCT studies was insignificant; however, pooled analysis of 28 prospective cohort studies showed a significant difference before and after the therapy, reducing both systolic blood pressure (SBP) and diastolic blood pressure (DBP) (MD=-4...
February 2024: Current Problems in Cardiology
https://read.qxmd.com/read/37967245/risk-and-incidence-of-endocrine-immune-related-adverse-effects-under-checkpoint-inhibitor-mono-or-combination-therapy-in-solid-tumors-a-meta-analysis-of-randomized-controlled-trials
#35
JOURNAL ARTICLE
Irfan Vardarli, Susanne Tan, Tim Brandenburg, Frank Weidemann, Rainer Görges, Ken Herrmann, Dagmar Führer
CONTEXT: Few meta-analyses on incidence of endocrine immune-related adverse effects (eirAEs) have been published and many trials have been published since. OBJECTIVE: We performed a comprehensive meta-analysis with updated literature to assess risk and incidence of eirAEs of any grade and grade 3 to 5 by immune checkpoint inhibitor (ICI) monotherapy or combination therapy in solid tumors. METHODS: An electronic search using PubMed/Medline, Embase, and the Cochrane Library was performed...
March 15, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/37965538/importance-of-optimizing-duration-of-adjuvant-immune-checkpoint-inhibitor-therapy-to-treat-postoperative-hepatocellular-carcinoma-after-conversion-therapy-a-case-report
#36
Jian-Rong Li, Da-Long Yang, Jin-Ming Wang, Wei Tian, Wei Wei, Cheng-Piao Luo, Lu-Nan Qi, Liang Ma, Jian-Hong Zhong
Patients with hepatocellular carcinoma at high risk of recurrence after hepatic resection or local ablation often undergo adjuvant immunotherapy with immune checkpoint inhibitors for 1 year in randomized controlled trials, but the appropriateness of this duration is controversial, especially given the risk of adverse events. Here we report the case of a 52-year-old Chinese man with initially unresectable multinodular recurrent hepatocellular carcinoma who underwent two cycles of transarterial chemoembolization, followed by hepatic resection and 24 months of adjuvant therapy with the PD-1 inhibitor tislelizumab...
November 2023: Journal of Surgical Case Reports
https://read.qxmd.com/read/37932681/novel-approach-of-prophylactic-radiation-to-reduce-toxicities-comparing-2-step40-with-56-gy-simultaneous-integrated-boost-intensity-modulated-radiation-therapy-for-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-an-intergroup-phase-iii-trial-jcog1912
#37
JOURNAL ARTICLE
Tomoya Yokota, Sadamoto Zenda, Takeshi Kodaira, Naomi Kiyota, Yasushi Fujimoto, Koichiro Wasano, Ryo Takahashi, Takashi Mizowaki, Akihiro Homma, Keita Sasaki, Ryunosuke Machida, Yuta Sekino, Haruhiko Fukuda
BACKGROUND: Chemoradiotherapy (CRT) with concurrent cisplatin is the standard of care as a nonsurgical definitive treatment for patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, CRT is associated with increased severe late adverse events, including swallowing dysfunction, xerostomia, ototoxicity, and hypothyroidism. Few strategies aimed at less invasive CRT without compromising treatment outcomes have been successful. The purpose of this study is to confirm the non-inferiority of reduced dose prophylactic radiation with 40 Gy compared to standard dose prophylactic radiation with 56 Gy in terms of the time to treatment failure (TTF) among patients with clinical stage III-IVB LA-SCCHN...
November 6, 2023: BMC Cancer
https://read.qxmd.com/read/37931426/prospective-study-of-risk-factors-for-postoperative-atrial-fibrillation-after-cardiac-surgery
#38
JOURNAL ARTICLE
Michael E Bowdish, Emilia Bagiella, Gennaro Giustino, Pavan Atluri, John H Alexander, Vinod H Thourani, James S Gammie, Joseph J DeRose, Wendy C Taddei-Peters, Neal O Jeffries, Patrick T O'Gara, Alan J Moskowitz, Marc Gillinov, Annetine C Gelijns, Gorav Ailawadi
INTRODUCTION: To examine risk factors for new-onset postoperative atrial fibrillation (POAF) after cardiac surgery. METHODS: Patients enrolled in the Cardiothoracic Surgical Trials Network multicenter, randomized trial of rate control versus rhythm control for POAF were included. Predictors of POAF were determined using multivariable logistic regression. RESULTS: Among the 2104 patients who were enrolled preoperatively, 695 developed POAF (33...
November 4, 2023: Journal of Surgical Research
https://read.qxmd.com/read/37926884/effects-of-physical-activity-on-thyroid-stimulating-hormone-levels-in-obese-metabolic-syndrome-patients-a-meta-analysis
#39
Batool Hassan, Basit Ansari, Sumaira Farooqui
Metabolic syndrome is a combination of multiple disorders that predispose an individual to risk of diabetes, obesity, cardiovascular diseases (CVDs), cerebrovascular accidents (CVAs), and insulin-resistance. Hypothyroidism is the most prevalent metabolic disorder causing obesity, followed by hypercortisolism and hypogonadism. Hence, this study aimed to determine the effects of various exercises on thyroid stimulating hormone (TSH) levels in obese patients with metabolic syndrome. The study conformed to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) standards...
November 2023: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/37869413/in-infertile-women-with-subclinical-hypothyroidism-with-or-without-thyroid-peroxidase-antibodies-serum-tsh-during-pregnancy-follows-preconception-values-and-thyroid-hormones-remain-stable
#40
JOURNAL ARTICLE
C De Geyter, L Matt, I De Geyter, R Moffat, C Meier
STUDY QUESTION: How does subclinical hypothyroidism, defined in infertile women during preconception by thyroid-stimulating hormone (TSH) >2.5 or >4.5 mIU/l, with or without thyroid peroxidase antibodies (anti-TPO) >100 IU/ml, impact thyroid hormone levels during pregnancy and after birth? SUMMARY ANSWER: During pregnancy, TSH levels remain similar to those in preconception, even with supplementary thyroxine, whereas the serum levels of anti-TPO progressively decline...
2023: Human Reproduction Open
keyword
keyword
116129
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.